Purpose: Temporal hypometabolism on fluorodeoxyglucose positron emission tomography (FDG-PET) is a common finding in patients with drug-resistant temporal lobe epilepsy (TLE). The pathophysiology underlying the hypometabolism, including whether it reflects a primary epileptogenic process, or whether it occurs later as result of limbic atrophy or as a result of chronic seizures, remains unknown. This study aimed to investigate the ontologic relationship among limbic atrophy, histological changes, and hypometabolism in rats.

Methods: Serial in vivo imaging with FDG-PET and volumetric magnetic resonance imaging (MRI) was acquired before and during the process of limbic epileptogenesis resulting from kainic acid-induced status epilepticus in the rat. The imaging data were correlated with histologic measures of cell loss, and markers of astrogliosis (glial fibrillary acid protein [GFAP]), synaptogenesis (synaptophysin), glucose transporter 1 (Glut1) and energy metabolism (cytochrome oxidase C), on brains of the animals following the final imaging point.

Key Findings: Hippocampal hypometabolism on FDG-PET was found to be present 24 h following status epilepticus, tending to lessen by 1 week and then become more marked again following the onset of spontaneous seizures. Atrophy of limbic structures was evident from 7 days post-SE, becoming progressively more marked on serial MRI over subsequent weeks. No relationship was observed between the severity of MRI-detected atrophy or CA1 pyramidal cell loss and the degree of the hypometabolism on FDG-PET. However, an inverse relationship was observed between hypometabolism and increased expression of the Glut1 and synaptophysin in the hippocampus.

Significance: These findings demonstrate that hypometabolism occurs early in the processes of limbic epileptogenesis and is not merely a consequence of pyramidal cell loss or the progressive atrophy of limbic brain structures that follow. The hypometabolism may reflect cellular mechanisms occurring early during epileptogenesis in addition to any effects of the subsequent recurrent spontaneous seizures.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1528-1167.2012.03525.xDOI Listing

Publication Analysis

Top Keywords

limbic atrophy
12
cell loss
12
hypometabolism
9
limbic epileptogenesis
8
status epilepticus
8
hypometabolism fdg-pet
8
spontaneous seizures
8
atrophy limbic
8
relationship observed
8
pyramidal cell
8

Similar Publications

Cortical lesions impact cognitive decline in multiple sclerosis via volume loss of nonlesional cortex.

Ann Clin Transl Neurol

December 2024

MS Center Amsterdam, Department of Anatomy and Neurosciences, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Objective: To assess the interrelationship between cortical lesions and cortical thinning and volume loss in people with multiple sclerosis within cortical networks, and how this relates to future cognition.

Methods: In this longitudinal study, 230 people with multiple sclerosis and 60 healthy controls underwent 3 Tesla MRI at baseline and neuropsychological assessment at baseline and 5-year follow-up. Cortical regions (N = 212) were divided into seven functional networks.

View Article and Find Full Text PDF

Divergent neurodegenerative patterns: Comparison of [F] fluorodeoxyglucose-PET- and MRI-based Alzheimer's disease subtypes.

Brain Commun

November 2024

Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, 171 77 Stockholm, Sweden.

[F] fluorodeoxyglucose (FDG)-PET and MRI are key imaging markers for neurodegeneration in Alzheimer's disease. It has been well established that parieto-temporal hypometabolism on FDG-PET is closely associated with medial temporal atrophy on MRI in Alzheimer's disease. Substantial biological heterogeneity, expressed as distinct subtypes of hypometabolism or atrophy patterns, has been previously described in Alzheimer's disease using data-driven and hypothesis-driven methods.

View Article and Find Full Text PDF

A visual scale to rate amygdalar atrophy on MRI.

Eur Radiol

December 2024

Geneva Memory Center, Department of Rehabilitation and Geriatrics, Geneva University Hospitals, Geneva, Switzerland.

Article Synopsis
  • A new visual rating scale for assessing amygdalar atrophy on MRI was developed, addressing a gap in evaluating conditions like limbic predominant age-related TDP-43 encephalopathy (LATE).
  • The scale demonstrated high reliability among neuroradiologists, with substantial to almost perfect agreement in ratings, and strong correlations with amygdalar volumes measured by an established imaging software.
  • This scale offers a validated tool that can enhance routine radiological assessments of neurodegenerative diseases.
View Article and Find Full Text PDF

Structural MRI correlates of cognitive and neuropsychiatric symptoms in Long COVID: a pilot study.

Front Psychiatry

December 2024

Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States.

Approximately 7% of COVID-19 patients (1.3% children) have exhibited symptoms of post-acute sequelae of SARS-CoV-2 infection (PASC), or Long COVID, and 20% of those present with neuropsychiatric symptoms. While a large number of MRI-based neuroimaging studies in this population have shown cortical atrophy in terms of gray matter volume and cortical thickness in patients, there is a growing body of work showing brain volume enlargements or thickness increases in patients compared to COVID negative controls.

View Article and Find Full Text PDF
Article Synopsis
  • * Research using cryo-electron microscopy reveals that the structure of α-synuclein filaments varies between different diseases, with a unique fold identified in atypical MSA that includes both neuronal and oligodendroglial pathology.
  • * The study suggests that different disease entities can be classified based on the specific folds of α-synuclein filaments, linking distinct biochemical properties of the protein to the types of cells affected in various conditions.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!